Results 171 to 180 of about 36,874 (293)

Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Sören Dräger   +8 more
wiley   +1 more source

Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of ...
Janis Chang   +3 more
wiley   +1 more source

Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Maren E. Buenning   +7 more
wiley   +1 more source

Long‐Term Outcomes of Prepubertal‐Onset Vulvar Lichen Sclerosus

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis affecting the vulvar and perianal skin. VLS has a bimodal age of onset, in pre‐pubertal and post‐menopausal age groups. Long‐term outcomes of pre‐pubertal VLS are unclear.
Alexandra Savage   +5 more
wiley   +1 more source

The puzzling effect of disease severity on quality of life in epidermolysis bullosa

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Vinzenz Hübl   +4 more
wiley   +1 more source

Dupilumab Reduces Pruritus in Twins With Sjögren–Larsson Syndrome

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Sjögren–Larsson Syndrome (SLS), now termed ALDH3A2‐syndromic epidermal differentiation disorder (sEDD), is a rare genetic disorder marked by thickened skin, spasticity, and intellectual disability. Intractable pruritus is a nearly universal and debilitating feature of SLS that remains poorly managed by current therapies. We describe 4‐year‐old
Kennedy Gallagher   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy